Matinas BioPharma Holdings stock price
NYSEAMERICAN:MTNB · NYSE Amex · Healthcare · sector #16Matinas BioPharma Holdings's chart data is dated 2026-10-21. There is no active technical signal. There are 4 published signal records.
Matinas BioPharma Holdings last closed at $1.52 (-10.59%) on 2026-10-21. Listed on NYSE Amex. Trailing 12 months PER is -0.1×. Its overall grade ranks 674 of 726 stocks in Healthcare.
About this company
Matinas BioPharma Holdings last closed at $1.52 (-10.59%) on 2026-10-21. Listed on NYSE Amex.
Details →Reported results
Position in sector
Healthcare · Overall F · 674/726
Valuation grade C+
Related stocks
- AstraZenecaCustomer
- PfizerCompetitor
- Merck & CoCompetitor
About Matinas BioPharma Holdings
- What technical signals does Matinas BioPharma Holdings (MTNB) have?
- Matinas BioPharma Holdings current technical signals: no active technical signal.
- Is Matinas BioPharma Holdings a cup-and-handle pattern?
- No. Matinas BioPharma Holdings has no valid Cup signal right now.
- What published figures are available for Matinas BioPharma Holdings?
- Market cap: $9.74M. Trailing 12 months PER: -0.1×. Latest quarter PBR: 0.40×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Matinas BioPharma Holdings, or open the plan table on the main site.
Ask Q about Matinas BioPharma Holdings.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.